A detailed history of Citigroup Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Citigroup Inc holds 528,502 shares of RPRX stock, worth $16.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
528,502
Previous 594,739 11.14%
Holding current value
$16.2 Million
Previous $15.7 Million 4.67%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$25.63 - $29.27 $1.7 Million - $1.94 Million
-66,237 Reduced 11.14%
528,502 $15 Million
Q2 2024

Aug 12, 2024

BUY
$26.26 - $29.9 $3.23 Million - $3.67 Million
122,896 Added 26.05%
594,739 $15.7 Million
Q1 2024

May 10, 2024

BUY
$27.46 - $31.33 $3.95 Million - $4.51 Million
143,850 Added 43.86%
471,843 $14.3 Million
Q4 2023

Feb 09, 2024

BUY
$26.21 - $29.22 $1.28 Million - $1.43 Million
48,840 Added 17.5%
327,993 $9.21 Million
Q3 2023

Nov 09, 2023

BUY
$26.26 - $31.38 $855,550 - $1.02 Million
32,580 Added 13.21%
279,153 $7.58 Million
Q2 2023

Aug 10, 2023

BUY
$29.6 - $36.56 $2.21 Million - $2.73 Million
74,629 Added 43.4%
246,573 $7.58 Million
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $2.27 Million - $2.72 Million
69,140 Added 67.25%
171,944 $6.2 Million
Q4 2022

Feb 09, 2023

SELL
$39.17 - $44.04 $802,162 - $901,895
-20,479 Reduced 16.61%
102,804 $4.06 Million
Q3 2022

Nov 10, 2022

BUY
$39.88 - $44.65 $354,652 - $397,072
8,893 Added 7.77%
123,283 $4.95 Million
Q2 2022

Aug 10, 2022

SELL
$37.53 - $44.22 $1.48 Million - $1.75 Million
-39,557 Reduced 25.7%
114,390 $4.81 Million
Q1 2022

May 12, 2022

BUY
$37.46 - $42.44 $1.39 Million - $1.57 Million
37,054 Added 31.7%
153,947 $6 Million
Q4 2021

Feb 10, 2022

SELL
$35.17 - $42.48 $480,598 - $580,489
-13,665 Reduced 10.47%
116,893 $4.66 Million
Q3 2021

Nov 10, 2021

BUY
$36.14 - $42.24 $4.72 Million - $5.51 Million
130,558 New
130,558 $4.72 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.4B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.